Differential effect of phenothiazines on MRP1 and P-glycoprotein activity

In Vivo

Volumn 23, Issue 6, 2009, Pages 943-947

  Wesołowska, Olga ^a   Molnar, Joseph ^b   Ocsovszki, Imre ^b   Michalak, Krystyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

ABCB1; ABCC1; MDR1; Modulators; MRP1; Multidrug resistance; Multidrug resistance associated protein 1; P glycoprotein; Phenothiazine derivatives

Indexed keywords

ABC TRANSPORTER; BENZBROMARONE; BREAST CANCER RESISTANCE PROTEIN; CHLORPROMAZINE; DIETHAZINE; FLUORESCENT DYE; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; LEVOMEPROMAZINE; MULTIDRUG RESISTANCE PROTEIN 1; ORTHOVANADIC ACID; PERPHENAZINE; PHENOTHIAZINE DERIVATIVE; RHODAMINE 123; THIETHYLPERAZINE; THIORIDAZINE; TRIFLUOPERAZINE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN;

EID: 75149133681     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dean M: The genetics of ATP-binding cassette transporters. Methods Enzymol 400: 409-429, 2005.
2. Lage H: ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents 22: 188-199, 2003.
3. Sharom FJ: ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9: 105-127, 2008.
4. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
5. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I and Gottesman MM: Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39: 361-398, 1999.
6. Keppler D, Leier I and Jedlitschky G: Transport of glutathione conjugates and glucuronides by the multidrug-resistance proteins MRPl and MRP2. Biol Chem 378: 787-791, 1997.
7. Ozvegy-Laczka C, Hegedus T, Varady G, Ujhelly O, Schuetz JD, Varadi A, Keri G, Orfi L, Nemet K and Sarkadi B: High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol Pharmacol 65: 1485-1495, 2004.
8. Michalak K, Wesolowska O, Motohashi N and Hendrich AB: The role of the membrane actions of phenothiazines and flavonoids as functional modulators. Top Heterocyclic Chem (Bioactive Heterocycles II) 8: 223-302, 2007.
9. Weiss B, Prozialeck W, Cimino M, Barnette MS and Wallace TL: Pharmacological regulation of calmodulin. Ann NY Acad Sci 356: 319-345, 1980.
10. Wennogle LP, Wysowskyj HE and Jeng AY: Profiling of inhibitors of protein kinase C. Adv Enzyme Regul 27: 287-293, 1988.
11. Clement-Cormier YC, Kebabian JW, Petzold GL and Greengard P: Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc Natl Acad Sci USA 71: 1113-1117, 1974.
12. Michalak K, Wesolowska O, Motohashi N, Molnar J and Hendrich AB: Interactions of phenothiazines with lipid bilayer and their role in multidrug-resistance reversal. Curr Drug Targets 7: 1095-1105, 2006.
13. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y: Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42: 4730-4733, 1982.
14. Ramu A and Ramu N: Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother Pharmacol 30: 165-173, 1992.
15. Molnar J, Szabo D, Mandi Y, Mucsi I, Fischer J, Varga A, König S and Motohashi N: Multidrug reversal in mouse lymphoma cells by heterocyclic compounds. Anticancer Res 18: 3033-3038, 1998.
16. Hendrich AB, Wesolowska O, Motohashi N, Molnar J and Michalak K: New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency. Biochem Biophys Res Commun 304: 260-265, 2003.
17. Hendrich AB, Wesolowska O, Pola A, Motohashi N, Molnar J and Michalak K: Neither lipophilicity nor membrane perturbing potency of phenothiazine maleates correlates with ability to inhibit P-glycoprotein transport activity. Mol Membr Biol 20: 53-60, 2003.
18. Wesolowska O, Mosiadz D, Motohashi N, Kawase M and Michalak K: Phenothiazine maleates stimulate MRPl transport activity in human erythrocytes. Biochim Biophys Acta 1720: 52-58, 2005.
19. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutheford AV and Willingham MC: A retrovirus carrying an MDRl cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Sci USA 85: 4486-4490, 1988.
20. Rychlik B, Balcerczyk A, Klimczak A and Bartosz G: The role of multidrug resistance protein MRP1) in transport of fluorescent anions across the human erythrocyte membrane. J Membr Biol 193: 79-90, 2003.
21. Hipfner DR, Deeley RG and Cole SPC: Structural, mechanistic and clinical aspects of MRPl. Biochim Biophys Acta 1461: 359-376, 1999.
22. Klokouzas A, Wu CP, van Veen HW, Barrand MA and Hladky SB: cGMP and glutathione-conjugate transport in human erythrocytes. The roles of the multidrug resistance-associated proteins, MRP1, MRP4 and MRP5. Eur J Biochem 270: 3696-3708, 2003.
23. Nguyen H, Zhang S and Morris ME: Effect of flavonoids on MRP1-mediated transport in PANC-1 cells. J Pharm Sci 92: 250-257, 2003.
24. Gyemant N, Tanaka M, Antus S, Hohmann J, Csuka O, Mandoky L and Molnar J: In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. In Vivo 19: 367-374, 2005.
25. Bakos E, Evers R, Sinko E, Varadi A, Borst P and Sarkadi B: Interactions of the human multidrug-resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol 57: 760-768, 2000.
26. Sauna ZE, Peng XH, Nandigama K, Tekle S and Ambudkar SV: The molecular basis of the action of disulfiram as a modulator of the multidrug-resistance- linked ATP-binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1). Mol Pharmacol 65: 675-684, 2004.
27. Nabekura T, Yamaki T, Ueno K and Kitagawa S: Inhibition of P-glycoprotein and multidrug-resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 62: 867-873, 2008.
28. Limtrakul P, Chearwae W, Shukla S, Phisalphong C and Ambudkar SV: Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone-resistance protein (ABCG2) and multidrug-resistance protein 1 (ABCC1), by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 296: 85-95, 2007.